首页 > 市场调查报告书 > 製药

癌症

市场调查报告书

商品编码

1490007

兽医肿瘤学市场，按动物类型、按治疗类型、按剂型、按应用、按分销渠道、按地区

Veterinary Oncology Market, By Animal Type, By Therapy Type, By Mode of Administration, By Application, By Distribution Channel, By Geography

出版日期: 2024年05月23日 | 出版商:

Coherent Market Insights | 英文 225 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2024年全球兽医肿瘤市场价值将达7.249亿美元，预计到2031年将达到15.637亿美元，2024年至2031年复合年增长率为11.6%。

报告范围		报告详情
基准年	2023年	2024年市场规模	7.249 亿美元
实际资料	2019-2023	预测期	2024-2031
2024-2031 年预测期间的复合年增长率：	11.60%	2031 年金额预测	15.637 亿美元

图：2024 年按地区分類的兽医肿瘤市场份额 (%)

由于动物保健支出的增加和宠物拥有量的增加，兽医肿瘤学市场正在显着增长。人类与动物关係的加深以及对伴侣动物癌症认识的不断提高，推动了对兽医肿瘤学先进诊断方法和治疗程序的需求。此外，狗和猫的淋巴瘤、乳腺癌、口腔黑色素瘤和肥大细胞瘤等癌症的发生率不断增加，增加了对有效治疗方案和早期检测的需求。越来越多的兽医肿瘤学家和肿瘤学专家以及对创新製剂开发的持续研究也进一步推动了全球市场的扩张。然而，与癌症治疗和诊断程序相关的高成本仍然是一个重大挑战。

市场动态：

全球兽医肿瘤学市场的成长是由伴同性动物癌症盛行率上升、宠物保险采用率上升、兽医医疗保健成本上升和技术进步所推动的。统计显示，10岁以上的狗狗有超过50%会罹患癌症，而淋巴瘤是狗狗最常见的血癌。快速的都市化、核心家庭和日益增加的孤独感正在推动全世界养宠物的人数增加。这使得宠物饲主更加关注宠物的健康，并花钱购买高端治疗。各种组织为与兽医肿瘤学相关的临床试验和研究活动提供财务支持，这在市场成长中发挥重要作用。然而，与肿瘤药物、诊断测试和手术相关的高昂成本以及新兴国家缺乏认知预计将阻碍预测期内的市场扩张。透过社群媒体宣传活动和会议不断努力传播人们对宠物癌症的认识，预计将为市场主要企业创造大量有利可图的机会。

本研究的主要特点

该报告对全球兽医肿瘤市场进行了详细分析，并提供了以2023年为基准年的预测期（2024-2031）的市场规模和年复合成长率（CAGR%）。
它还揭示了各个细分市场的潜在收益成长机会，并说明了该市场有吸引力的投资提案矩阵。
它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。
它根据公司亮点、产品系列、主要亮点、财务表现和策略等参数，介绍了全球兽医肿瘤学市场的主要企业。
主要公司包括 Zoetis Inc.、Elanco、AB Science、Boehringer Ingelheim International GmbH、Zenoaq、VetDC、Morphogenesis, Inc.、Karyopharm Therapeutics, Inc.、Regeneus Ltd.、AdvaVet, Inc.、Rhizen Pharmaceutical SA.、PetCure Oncology 、VarVet Medical Systems、Accuray Incorporated、One Health 与Regeneus Ltd.
该报告的见解使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
全球兽医肿瘤学市场迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
相关人员可以透过用于分析全球兽医肿瘤学市场的各种策略矩阵来促进决策。

公司简介
- Zoetis Inc.
- Elanco
- AB Science
- Boehringer Ingelheim International GmbH
- Zenoaq
- VetDC
- Morphogenesis, Inc.
- Karyopharm Therapeutics, Inc.
- Regeneus Ltd.
- AdvaVet, Inc.
- Rhizen Pharmaceutical SA.
- PetCure Oncology
- Varian Medical Systems
- Accuray Incorporated
- One Health
- Regeneus Ltd.

第十二章分析师建议

命运之轮
分析师观点
Coherent Opportunity Map

第十三章参考文献与调查方法

参考
调查方法

简介目录

Product Code: CMI2995

Global veterinary oncology market is estimated to be valued at USD 724.9 Mn in 2024 and is expected to reach USD 1,563.7 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 11.6% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2024:	US$ 724.9 Mn
Historical Data for:	2019 To 2023	Forecast Period:	2024 To 2031
Forecast Period 2024 to 2031 CAGR:	11.60%	2031 Value Projection:	US$ 1,563.7 Mn

Figure. Veterinary Oncology Market Share (%), By Region, 2024

The veterinary oncology market is experiencing significant growth due to rising animal healthcare expenditure and increasing pet ownership. Growing human-animal bonds and rising awareness about cancer in companion animals are propelling demand for advanced diagnostic methods and therapeutic procedures for veterinary oncology. Moreover, increasing incidence of cancers such as lymphoma, mammary tumor, oral melanoma, and mast cell tumors in dogs and cats is driving the need for effective treatment options and early detection. Growing number of veterinary oncologists and oncology specialists along with ongoing research for developing innovative drug formulations are further supporting market expansion on a global level. However, high costs associated with cancer therapies and diagnostic procedures remain a major challenge.

Market Dynamics:

The global veterinary oncology market growth is driven by rising incidence of cancer in companion animals, increase in pet insurance purchases, growing animal health expenditure, and technological advancements. According to statistics, over 50% of dogs over the age of 10 will develop cancer and lymphoma is the most common blood cancer in dogs. Rapid urbanization accompanied with rising nuclear families and increasing loneliness levels have boosted pet adoption rates globally. This has led to pet owners becoming more aware regarding the health of their pets and willing to spend more on premium treatments. Various organizations are financially supporting clinical trials and research activities related to veterinary oncology which is playing a significant role in market growth. However, high costs associated with oncology medications, diagnostic tests, surgeries, and lack of awareness in developing nations are anticipated to hamper the market expansion during the forecast period. Ongoing initiatives to spread awareness regarding cancer in pets through social media campaigns and conferences are expected to bring numerous lucrative opportunities for key players in the market.

Key Features of the Study:

This report provides an in-depth analysis of the global veterinary oncology market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global veterinary oncology market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this includes Zoetis Inc., Elanco, AB Science, Boehringer Ingelheim International GmbH, Zenoaq, VetDC, Morphogenesis, Inc., Karyopharm Therapeutics, Inc., Regeneus Ltd., AdvaVet, Inc., Rhizen Pharmaceutical SA., PetCure Oncology, Varian Medical Systems, Accuray Incorporated, One Health, and Regeneus Ltd.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global veterinary oncology market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global veterinary oncology market

Detailed Segmentation-

By Animal Type:
- Companion Animal
- Equine
- Canine
- Feline
- Livestock Animal
By Therapy Type:
- Chemotherapy
- Combination Therapy
- Immunotherapy
- Targeted Therapy
By Mode of Administration:
- Oral
- Intravenous
By Application:
- Canine Lymphoma
- Osteosarcoma (OSA)
- Mast Cell Cancer
- Melanoma
- Others
By Distribution Channel:
- Hospital Pharmacies
- Government Agencies
- Retail Pharmacies
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Zoetis Inc.
- Elanco
- AB Science
- Boehringer Ingelheim International GmbH
- Zenoaq
- VetDC
- Morphogenesis, Inc.
- Karyopharm Therapeutics, Inc.
- Regeneus Ltd.
- AdvaVet, Inc.
- Rhizen Pharmaceutical SA.
- PetCure Oncology
- Varian Medical Systems
- Accuray Incorporated
- One Health
- Regeneus Ltd.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Animal Type
- Market Snapshot, By Therapy Type
- Market Snapshot, By Mode of Administration
- Market Snapshot, By Application
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Epidemiology
Market Trends
Key Developments
Regulatory Scenario
Acquisitions and Partnerships Scenario
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Veterinary Oncology Market - Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the Market

5. Global Veterinary Oncology Market, By Animal Type, 2019 - 2031, (USD Mn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Companion Animal
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Equine
Canine
Feline
Livestock Animal
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

6. Global Veterinary Oncology Market, By Therapy Type, 2019 - 2031, (USD Mn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Chemotherapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Combination Therapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Immunotherapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Targeted Therapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

7. Global Veterinary Oncology Market, By Mode of Administration, 2019 - 2031, (USD Mn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Oral
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Intravenous
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

8. Global Veterinary Oncology Market, By Application, 2019 - 2031, (USD Mn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Canine Lymphoma
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Osteosarcoma (OSA)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Mast Cell Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Melanoma
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

9. Global Veterinary Oncology Market, By Distribution Channel, 2019 - 2031, (USD Mn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Government Agencies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

10. Global Veterinary Oncology Market, By Region, 2019 - 2031, (USD Mn)

Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2031
- Regional Trends
  - North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Mode of Administration, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
  - U.S.
  - Canada
  - Latin America
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
  - Europe
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
  - Asia Pacific
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
  - Middle East
  - GCC
  - Israel
  - Rest of Middle East
  - Africa
  - North Africa
  - Central Africa
  - South Africa

11. Competitive Landscape

Company Profiles
- Zoetis Inc.*
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Elanco
- AB Science
- Boehringer Ingelheim International GmbH
- Zenoaq
- VetDC
- Morphogenesis, Inc.
- Karyopharm Therapeutics, Inc.
- Regeneus Ltd.
- AdvaVet, Inc.
- Rhizen Pharmaceutical SA.
- PetCure Oncology
- Varian Medical Systems
- Accuray Incorporated
- One Health
- Regeneus Ltd.

12. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

13. References and Research Methodology

References
Research Methodology
About us and Sales Contact

02-2729-4219

+886-2-2729-4219

License/价格

兽医肿瘤学市场，按动物类型、按治疗类型、按剂型、按应用、按分销渠道、按地区